Associate Director at MedImmune to Present at GTCbio’s 2nd Rediscovering Biomarkers Conference

Robert Lechleider, Associate Director at MedImmune to Present at GTCbio’s 2nd Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA

April 24, 2008 (FPRC) -- Dr. Robert Lechleider, Associate Director at MedImmune will be speaking at GTCbio’s 2nd Annual Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA. Dr. Lechleider will present on “Biomarkers in Oncology Drug Development: The Road to Shangri-La?”
Much hype has surrounded the use of biomarkers to speed the approval process in drug development. This is especially evident in oncology, where clinical endpoints can take months or years to meet, and the use of biomarkers to expedite trial completion and regulatory approval has been highly touted. But biomarkers have not yet delivered on the promises their supporters have made for them. Few biomarkers have been incorporated into clinical trials in a successful manner. Using biomarkers effectively requires the understanding of how they should be incorporated into clinical trial design, including understanding the different types of biomarkers, how to incorporate various biomarkers into clinical trial design, what regulatory considerations the FDA and other agencies will use, and how best to integrate the best scientific approach with a sound regulatory strategy.
The 2nd Annual Rediscovering Biomarkers Conference will expose attendees to the latest advancements and developments in biomarkers and predictive medicine. Attendees will gain insight into discovery and development processes, hear about new biomarkers and upcoming trends in the industry, as well as the status of those in clinical trials. Delegates will also receive highly valuable information on tools for improving reimbursement strategies and the efficacy and validation of biomarkers.

For more information including a detailed agenda, exhibitor opportunities and registration information visit http://gtcbio.com/conferenceDetails.aspx?id=124
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, infogtcbio@gtcbio.com


For more information contact Rania Hafez of GTCbio (http://www.gtcbio.com)
(626) 256-6405

Keywords: biomarkers

You can read this press release online at: http://www.free-press-release-center.info/pr00000000000000013994.html